Company Management

PDC*line Pharma

Biotechnology Research Liege, Liège, Be 32 employees

Employees: 32

pdc-line-pharma.com LinkedIn Crunchbase

PDC*line Pharma Overview

Headquarters: Liege, Liège, Be
Phone Number: Available in AeroLeads
Website: pdc-line-pharma.com
Industry: Biotechnology Research
Employees: 32
Founded: 2014
Funding: 13.3M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Cancer immunotherapy Therapeutic vaccines Clinical development Plasmacytoid Dendritic Cells neoantigens

About PDC*line Pharma

PDC*line Pharma is a clinical-stage Biotechnology company that develops a new class of potent, off-the-shelf therapeutic cancer vaccines based on a proprietary cell line of Plasmacytoid Dendritic Cells (PDC*line). Based on a robust preclinical package and a first-in-human phase Ib in melanoma, PDC*line Pharma reported promising Phase I/II results in lung cancer (PDC*lung) in 2024. Preparations are now underway for a randomized Phase II trial in lung cancer, and a Phase Ib trial in colorectal cancer with neoantigens (PDC*neo). The company has raised €61M in equity and non-dilutive funding and signed a €108M licensing deal in Asia with the Korean pharmaceutical company, LG Chem Life Science.

PDC*line Pharma Contact Details

People in AeroLeads: 3

PDC*line Pharma Org Chart

Sample employees and titles

Name	Title	Contact
Laurent Levy	Biotech Leader & Growth Architect - Strategy, Fundraising & Scaling - Seed to Clinical Stage	View
Eric Halioua	President & Chief Executive Officer at Pdc*line Pharma	View
Florence Renard	Sr. Clincial Project Manager	View